Member Info for Toffers

“At a moment when the line between machine and human capabilities is blurring, Cykel's mission is to guide that transition responsibly. We're creating an intelligent layer for the internet, setting a new standard for what 'work' could and should be.”

Jonathan Bixby

Co-Founder, Cykel AI

Https://techcrunch.com/2025/06/01/for-the-love-of-god-stop-calling-your-ai-a-co-worker/

Https://techcrunch.com/2025/06/02/salesforce-buys-moonhub-a-startup-building-ai-tools-for-hiring/

Hi Trent, I'm a lass, holding 4 mill shares+! Come on, you need to catch up! You can do it :)

The 397375 shown in red is a buy, as it's one of mine today.

02/06/2025 04/06/2025 BXXXXXXXX4 Cykel AI Plc ORD GBP0.01 397375 @ 2.5025 2.5025 397,375 -9,999.98

Jundee, you say "Clear Capital also have 40,000,000 warrants from memory so wait until if they start exercising, it’s going nowhere. It’s a massive pump and dump rinse and repeat stock. People open your eyes it’s all there to see."

But Jonathan Plant of Clear Capital gave a target price of 65p just 6 months ago in December 2024, and for that price to be reached within 12-18 months or so, so why would they get rid of any warrants if they believe the sp will go to 65p? There's no logic to your argument, nothing to back it up at all.

Anyone worked out yet the significance to Cykel?

https://blogs.nvidia.com/blog/ai-agents-blueprint/

Is a networking powerhouse, don't underestimate it people!

Cykel AI Secures Enterprise-Level Commercial Agreement with Transpharmation, Generating New Revenue Stream in Pharmaceutical Sector

Cykel AI PLC (LSE: CYK) is pleased to announce the signing of a commercial agreement with Transpharmation Ltd., a global leader in neuroscience, pain and metabolic disease preclinical contract research. Transpharmation will deploy Lucy, Cykel's AI recruitment agent, across their UK and North American operations, opening a new revenue stream for Cykel in the pharmaceutical research sector. The agreement includes an initial 12-month term with renewal options for Lucy's Enterprise plan.

Coming after Transpharmation's recent acquisition of biomarker technology provider Saretius, this commercial deployment supports Transpharmation's market leadership in pharmaceutical research services. With over 150 employees and sites spanning two continents, Transpharmation has chosen an enterprise subscription to support the expansion of their team and operations.

Dr Mark Duxon PhD, Chief Executive Officer at Transpharmation Ltd, said: "As a company dedicated to advancing therapeutic medicine through cutting-edge research, we recognise the importance of securing the brightest scientific minds. Our investment in Cykel's AI recruitment technology reflects our commitment to innovation not just in our research methodologies, but in how we acquire talent efficiently and cost-effectively. After evaluating multiple options, we selected Lucy for her autonomous recruitment capabilities and alignment with our mission to build world-class research teams while optimising operational expenses."

Transpharmation has subscribed to Cykel's Enterprise plan, which carries the highest subscription value in Cykel's tiered pricing model. This premium subscription provides access to Lucy's full suite of functionalities, including:

● AI-powered search across 300 million professional profiles

● Automated multi-channel outreach

● Integration with ATS systems

● Advanced AI screening and talent matching

● Customisation options tailored to Transpharmation's requirements

● Unlimited workspace capacity to support their global operations

With the global pharmaceutical market valued at £1.25 trillion in 2023, this agreement underscores Lucy's commercial value proposition in this high-growth segment and marks a step forward in Cykel's ability to monetise its technology in regulated, knowledge-intensive industries.

Ewan Collinge, CEO & Founder of Cykel AI, commented: "Securing Transpharmation as a customer endorses our commercial strategy and product-market fit in knowledge-intensive sectors. This agreement not only generates revenue but establishes a foundation for expanded commercial opportunities as Transpharmation explores additional digital workers in their operations. The enterprise-level contract reflects the scalability of our pricing model and our ability to convert market-leading companies into customers."

Cykel AI PLC (LSE: CYK) is pleased to announce its acceptance into NVIDIA Connect, marking another strategic advancement in the Company's technological capabilities. NVIDIA Connect is a free program that helps software development companies and service providers accelerate time-to-market by leveraging the latest technological innovations from NVIDIA. Members have access to developer resources, technical guidance, preferred pricing, and marketing opportunities.

NVIDIA Connect is expected to equip Cykel AI with tailored development resources, accelerated product development capabilities and direct access to an extensive network of industry innovators. The Company intends to benefit from personalised SDK recommendations, advanced technical training and early access to NVIDIA's latest AI technologies and solutions.

The programme also offers preferential pricing structures that are expected to optimise Cykel AI's operational costs. These combined advantages will accelerate time to market and technical capabilities across Cykel's growing portfolio of autonomous digital workers - Lucy (recruitment), Samson (research analysis) and Eve (sales) - and further automate high-value business workflows.

Ewan Collinge, CEO & Founder of Cykel AI, commented: "Joining NVIDIA Connect represents a significant enhancement to our technological infrastructure. NVIDIA's AI acceleration capabilities perfectly complement our TaskOS platform, allowing us to further optimise the performance of our digital workers whilst reducing computational costs. This collaboration supports our mission to democratise access to enterprise-level AI solutions for businesses of all sizes."

This announcement comes as the Company continues to experience traction across its digital worker portfolio, with an expanding pipeline of enterprise engagements and early adopter deployments. The enhanced technical capabilities offered through NVIDIA Connect are expected to further accelerate product development and market penetration in Q2 2025.

Come on Cykel, you need to get the rumour mill operational. Who is buying all the stock every afternoon? Nvidia whom we've recently connected to? and that's no mean feat. IBM? Google? LinkedIN? Trustpilot whom we already have a partnership with? an outfit in Canada?

What the heck, I can see a rise coming within the next few days!

Jundee, are you Anxiety by any chance?!!!! LOL

Looks like LinkedIn is very much in vogue with Cykel!

IT'S ALL IN THE DATA! THE DATA IS THE BIGGEST PLUS POINT.

The blanked out bit is research tree

Https://www.cykel.ai/integrations

https://*********************/newsfeed/article/cykel-ai-plc-cykel-ai-unveils-eve-advanced-ai-sales-agent-2864317

In less than a week! That's pretty good going!

"With Eve, we're addressing one of the most significant challenges businesses face: scaling effective sales operations without proportionally scaling costs. Eve is designed to execute complex sales workflows autonomously at machine speed, enabling sales teams to focus on relationship-building and closing deals while routine prospecting and nurturing happens 24/7 in the background. I'd like to congratulate the team on their execution - delivering Eve so soon after our release of Lucy and Samson."This launch comes as the global AI agents market is now projected to surge from USD 5.29 billion in 2023 to USD 216.8 billion by 2035. As a publicly traded pure-play AI agent company, Cykel AI provides investors with direct exposure to this high-growth sector through public markets."

I'm sitting tight TWK- this is just panic mode by some, but we knew what was going to be in this, if they produced it now, and itshenderz was right on that, all credit to him, so we knew what was coming, and wolfi is right to state that these financials were done before the agents were in play, so onwards and upwards from here, plus someone has been buying the shares for months in a million to four million buys at a time in the afternoons, so someone is stocking up. They've announced that they intend to do the bitcoin stuff with a deadline of 6 June for them to decide, so I wonder whether they are going to announce some good news prior to that in the next 4 days? It really is one of those shares that if you're out, you're out! It is a gamble with a fledgling company at 50/50, no doubt about it, but folks knew what they were investing in, and the margins have recently changed imo to 60/40 in favour of this being fruitful imo. All to play for. Not financial advice. Someone will pick up the shares for sure!